Los Angeles Capital Management LLC Maravai Lifesciences Holdings, Inc. Transaction History

Los Angeles Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 05, 2024	BUY	$5.11 - $8.76 $110,340 - $189,154	21,593 New	21,593 $187,000
Q3 2023 Nov 06, 2023	SELL	$9.14 - $12.85 $18,572 - $26,111	-2,032 Reduced 16.63%	10,187 $101,000
Q4 2022 Feb 06, 2023	BUY	$12.5 - $24.78 $152,737 - $302,786	12,219 New	12,219 $174,000
Q2 2022 Aug 05, 2022	SELL	$26.05 - $37.48 $862,333 - $1.24 Million	-33,103 Reduced 28.99%	81,092 $2.3 Million
Q1 2022 May 06, 2022	BUY	$24.46 - $40.92 $1.62 Million - $2.71 Million	66,134 Added 137.6%	114,195 $4.03 Million
Q4 2021 Feb 03, 2022	BUY	$35.0 - $45.94 $419,090 - $550,085	11,974 Added 33.18%	48,061 $2.01 Million
Q3 2021 Nov 08, 2021	SELL	$36.8 - $60.62 $15.4 Million - $25.3 Million	-417,506 Reduced 92.04%	36,087 $1.77 Million
Q2 2021 Aug 05, 2021	BUY	$32.46 - $45.0 $14.7 Million - $20.4 Million	453,593 New	453,593 $18.9 Million

227

140M

237K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $650M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.